Aplagon Raises €7 Million in Equity Funding
Aplagon, a Finland-based clinical-stage biopharmaceutical company, raised €7 million in equity funding. The funding round was co-led by new investors Fahraeus Startup and Growth AB … Read more…
Aplagon, a Finland-based clinical-stage biopharmaceutical company, raised €7 million in equity funding. The funding round was co-led by new investors Fahraeus Startup and Growth AB … Read more…
AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, raised US$112 million in Series C financing. SV Health Investors, Sanofi Ventures, Abingworth, and SymBiosis co-led … Read more…
Orbis Medicines, a Denmark-based oral macrocycle drug discovery company, raised €90 million in Series A funding. New Enterprise Associates (NEA) led the investment round with … Read more…